Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy of Ramelteon in Adults With Chronic Insomnia

ClinicalTrials.gov ID: NCT00672724

Public ClinicalTrials.gov record NCT00672724. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Subjective Response to Treatment With Ramelteon in Adult Subjects With Chronic Insomnia by Utilizing an Interactive Voice Response System (IVRS) for Collecting Diary Data

Study identification

NCT ID
NCT00672724
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
1,081 participants

Conditions and interventions

Interventions

  • Ramelteon Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2005
Primary completion
Jul 31, 2005
Completion
Jul 31, 2005
Last update posted
Feb 27, 2012

2005

United States locations

U.S. sites
43
U.S. states
20
U.S. cities
43
Facility City State ZIP Site status
Not listed Mesa Arizona
Not listed Phoenix Arizona
Not listed Scottsdale Arizona
Not listed Hot Springs Arkansas
Not listed Cerritos California
Not listed La Jolla California
Not listed La Mesa California
Not listed Oakland California
Not listed Denver Colorado
Not listed Bay Harbor Island Florida
Not listed Brandon Florida
Not listed Clearwater Florida
Not listed DeLand Florida
Not listed Fort Lauderdale Florida
Not listed Fort Myers Florida
Not listed Hollywood Florida
Not listed Miami Florida
Not listed Pembroke Pines Florida
Not listed Pinellas Park Florida
Not listed Vero Beach Florida
Not listed Atlanta Georgia
Not listed Austell Georgia
Not listed Macon Georgia
Not listed Boise Idaho
Not listed Northbrook Illinois
Not listed Prairie Village Kansas
Not listed Wichita Kansas
Not listed Louisville Kentucky
Not listed Frederick Maryland
Not listed Moorestown New Jersey
Not listed Menlius New York
Not listed New York New York
Not listed Williamsville New York
Not listed Salem North Carolina
Not listed Winston-Salem North Carolina
Not listed Cincinnati Ohio
Not listed Mogadore Ohio
Not listed Philadelphia Pennsylvania
Not listed Bristol Tennessee
Not listed Chattanooga Tennessee
Not listed Dallas Texas
Not listed Fairfax Virginia
Not listed Tacoma Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00672724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00672724 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →